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Abstract
Background: Genetic predisposition to the clinical categories of coronary artery disease (anatomical viz., insignificant,
single, double, and triple vessel diseases and phenotypic severity categories viz., angina, acute coronary syndrome, and
myocardial infarction) is poorly understood. Particularly, the apolipoprotein genes clustered at 11q23.3 chromosomal
region play a vital role in cholesterol homeostasis, and a large number of SNPs identified in this region need to be
explored for their association with the clinical categories of CAD.
Methods: Using fluidigm SNP genotyping platform, a prioritized set of 96 SNPs of 11q23.3 chromosomal region were
genotyped on 508 CAD cases and 516 ethnicity matched controls, enrolled from Hyderabad, India, and its vicinity.
Results: The association analysis suggests 19 and 15 SNPs to be significantly associated (p≤ 0.05) with at least one of
the anatomical and/or phenotypic severity categories, respectively. Overall, the six SNPs rs17440396:G>A, rs6589566:
A>G, rs2849165:G>A, rs10488699:G>A, rs1263163:G>A, and rs1263171:G>A were significant even after correction for
multiple testing. Three of these (rs17440396:G>A, rs6589566:A>G, and rs2849165:G>A) that belong to BUD13, ZPR1, and
APOA5-APOA4 intergenic regions, respectively, were found to be associated across the anatomical categories of CAD.
However, no particular trend in the genotypic odds ratios with the increasing severity was apparent. The association
analysis of the variants with phenotypic severity categories suggests that a high degree of phenotypic severity could
be a result of more number of risk alleles. While the risk score analysis suggests high discriminative power of the
variants towards the individual clinical categories of CAD, the complex network of interactions seen between the
intronic variants of BUD13 and ZPR1 regulatory genes and intergenic variants of APOA5-APOA4 suggests pleiotropic
effects of regulatory genes in the manifestation of these CAD categories.
Conclusion: The complex network of interactions observed in the present study between the regulatory and
protein-coding genes suggests their role in the manifestation of distinct clinical categories of CAD, which
needs to be functionally validated.
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Background
Coronary artery disease (CAD) results from a progressive
damage of blood vessels that supply blood to the heart
muscle. It is caused by a process of hardening of arteries
called atherosclerosis, which involves both genetic and en-
vironmental factors and interaction between them. A large
number of genes that belong to lipoprotein metabolism
are found associated with monogenic and polygenic forms
of CAD [1]. Particularly, APOA1, APOC3, APOA4, and
APOA5 genes clustered in 11q23.3 human chromosomal
region are predominantly expressed in the liver and intes-
tine and crucial in regulating lipoprotein metabolism and
cholesterol homeostasis [2]. However, several variants that
belong to this apolipoprotein gene cluster region were
found to be associated with increased risk towards overall
CAD phenotype and/or elevated lipid traits among the
Indians [3–6]. Our recent study based on the 96 SNPs
from this region suggested distinct patterns of association
of these variants with CAD and dyslipidemia. This
pleiotropic nature of association was explained by the
observed SNP-SNP interactions between regulatory and
apolipoprotein coding genes [6].
CAD is identified as a broad phenotype that manifests
as less severe stable angina (SA) or unstable angina (UA)
and more severe forms like acute coronary syndrome
(ACS) and myocardial infarction (MI). Further, the
advanced coronary angiography modalities classify CAD
cases into distinct anatomical categories depending upon
the number of vessels and length and diameter of the
atherosclerotic lesions in the coronary blood vessels.
However, defining CAD cases is difficult due to the
process of multi-decadal atherosclerotic phenomenon
that can manifest any of the CAD conditions. With the
characteristic clinical heterogeneity and the difficulty in
defining CAD cases, it has become a challenging trait to
study [7]. There was substantial phenotypic heterogen-
eity of the samples hitherto considered for genetic asso-
ciation studies and that might be one of the reasons for
the lack of consistency in the findings of those studies
[8]. The couple of studies on the genetic predisposition
to anatomical categories were restricted to 9p21.3 locus
among the Caucasians [9, 10], except for an increasing
genotypic odds ratio observed with increasing number
of diseased blood vessels in case of a single polymorph-
ism of the APOA1 gene (−75G>A (MspI)) in two
independent studies, among the north Indian [11] and
Australian populations [12]. Despite the vital role in the
process of atherosclerosis envisaged for the apolipopro-
tein genes clustered at 11q23.3 chromosomal region, no
further attempts were made to understand their associa-
tions with anatomical or phenotypic severity categories
of CAD. Given the characteristic dyslipidemic feature of
Indian populations in general and particularly of the
southern Indians, it is pertinent to explore the pattern of
association of the variants of this genomic region with
each of the anatomical and phenotypic severity categor-
ies of CAD, which might throw light on the possible
genetic mechanisms responsible for progression of the
disease. We present here the results of our association
analysis of a prioritized set of 96 SNPs at 11q23.3 region
with sub phenotypes of CAD classified according to
anatomical and phenotypic severity.
Methods
The study design and population
The population of Hyderabad is a conglomeration of people
from different parts of the undivided state of Andhra
Pradesh, and the mother tongue of most of its populations
is Telugu, one of the four Dravidian languages. It would be
also pertinent to note that despite the subdivision of Telugu
population into a number of traditionally endogamous
castes and subcastes, Reddy et al. [13] observed genetic dif-
ferentiation among the populations of Andhra Pradesh to
be very low and insignificant; the Markov chain Monte
Carlo analysis of population structure, which implements
model-based clustering method for grouping individuals
into populations, did not reveal any unique population
clusters, suggesting high degree of genetic homogeneity.
A total of 1024 individuals, including 508 CAD cases
and 516 controls, representing the population of Hydera-
bad, participated in our case-control study. Patients with
characteristic symptoms of stable/unstable angina pectoris
along with varying degrees (generally >40%) of stenosis in
at least one of the major coronary arteries as determined
through angiogram were included in the study. Cases with
monogenic diseases, valvular heart disease, cardiomyop-
athy, renal disease, acute and chronic viral or bacterial
infections, asthma, tumors or connective tissue diseases,
and other vascular diseases were excluded from the study.
All the cases were recruited at the CARE Hospitals,
Hyderabad, and evaluated by interventional cardiologists
for the above mentioned criteria. Control samples were
recruited by conducting free health camps in and around
Hyderabad, mostly representing subjects aged above
45 years and with similar ethnic backgrounds as that of
the cases. The individuals with characteristic features of
any of the above mentioned disease conditions were not
included as part of the controls. However, certain propor-
tions of both the case and control subjects were found
with T2DM, dyslipidemia, and hypertension.
Data and sample collection
Data pertaining to present age, sex, and age at diagnosis
for cases and other background information such as his-
tory and current status of smoking, alcoholism, and food
habits were obtained through a detailed questionnaire.
Information regarding the current status of the subjects
on diabetes, dyslipidemia, and hypertension were drawn
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from hospital records for the cases and through personal
interviews for the controls. About 5–6 ml of fasting
blood sample was collected peripherally by certified
medical lab technicians. Clinical investigations were
done for lipid profile and blood sugar for all the samples
at Tapadia Diagnostic Centre, Hyderabad, using Auto
Analyzer. Blood pressure along with height, weight,
waist circumference, and hip circumference were also
measured in the field for all the controls, and for the
cases, these data were obtained from hospital records.
DNA isolation, SNP selection, and genotyping
DNAs were isolated from all the samples using phenol
chloroform method [14] and quantified with the help of
Thermo Scientific Varioskan™ Flash Multimode Reader
using Quant-iT™ PicoGreen® dsDNA Assay Kit. In order
to comprehensively genotype the variants at 11q23.3
chromosomal region, we gathered information on SNPs
pertaining to this region from earlier candidate gene and
sequencing studies and from databases particularly EBI-
NHGRI GWAS database, HAPMAP and dbSNP. Given the
key role of BUD13 in splicing mechanism and ZPR1 as
essential protein for normal cell proliferation and signal
transduction, in addition to the SNPs of APOAI-CIII-AIV-
AV genes clustered at 11q23.3 chromosomal region, we also
included SNPs related to these regulatory protein-coding
genes. A total of 130 SNPs, studied through candidate gene
and GWAS approaches, were subjected to Fluidigm D3
Assay design software [15], and a panel of 96 SNPs with
high efficiency for genotyping was chosen. Genotyping was
performed using fluidigm nanofluidic SNP genotyping sys-
tem. Eleven 96.96 IFC chips were utilized for genotyping
wherein the selected 96 SNPs were analyzed against 96
samples in each chip. These chips were thermal cycled, and
the endpoint fluorescent values were measured on
Biomark™ system. Final sample wise genotype calls were
obtained using Fluidigm SNP Genotyping Analysis soft-
ware. A subset of 240 samples was genotyped prior to
genotyping of the total 1024 samples. The observed call
concordance was 100%.
Prior to genetic association analysis, data quality control
was achieved by limiting the sample wise call rate to
≥90%. This resulted in a genotype call rate of 99% in 386
cases and 462 controls, which were considered for further
analysis. Further, after excluding SNPs that showed either
minor allele frequency <1% and/or deviated from hardy
Weinberg equilibrium (p < 0.001), only 75 of the 96 SNPs
were qualified for final analysis.
Clinical categories of the CAD cases
The CAD cases were categorized into the following four
anatomical sub types : (i) cases with 40–70% stenosis and
symptomatic for CAD with characteristic atherosclerotic
lesions as “insignificant disease,” (ii) with >70% stenosis in
any one of the major coronary blood vessel as “single ves-
sel disease (SVD),” (iii) with >70% stenosis in two major
coronary blood vessels as “double vessel disease (DVD),”
and (iv) with >70% stenosis in three major coronary blood
vessels are categorized as “triple vessel disease (TVD).”
After the genotype pruning, 93 cases with insignificant
stenosis, 121 with SVD, 75 with DVD, and 70 with TVD
remained with approximately 99% genotype call rate. We
also categorized the cases based on the phenotypic sever-
ity into three broad classes, (i) those with characteristic
symptoms of stable or unstable angina (SA/US), (ii) with
symptoms of acute coronary syndrome (ACS), and (iii)
with reported myocardial infarction (MI). After the geno-
type pruning, 73 cases with SA/UA, 165 with ACS, and 76
with MI remained with approximately 99% genotype call
rate. The cases that could not be assigned to any of the
anatomical/phenotypic severity categories were excluded
from the association analysis.
Statistical methods
The descriptive statistical analysis of the background
data on quantitative variables was done using MINITAB
(version 17). Genotyping quality check and association
analysis of alleles were done using PLINK [16].
Genotype-phenotype association analysis using logistic
regression assuming different genetic models-dominant,
co-dominant, recessive, over dominant, and log-additive
were performed using “SNPassoc” package of R PRO-
GRAM [17].
Results and discussion
The means and standard deviations of quantitative
parameters along with t values for the difference in
means of controls and each of the anatomical and
phenotypic severity categories are provided in
Additional files 1 and 2, respectively. The average age
of individuals of the TVD category is significantly
higher than that of controls as well as other less
severe anatomical categories. Analysis of variance sug-
gests significant heterogeneity in the mean age of
subjects among the anatomical categories, which is
because of the difference between the average age of
TVD and all other anatomical categories. When com-
pared to controls, a significant increase in the means
of fasting blood sugar (FBS) and decrease in mean
high density lipoprotein cholesterol (HDLC) and the
low density lipoprotein cholesterol (LDLC) levels were
observed in each of the anatomical and phenotypic
severity categories. The elevated levels of triglycerides
(TG) and very low density lipoproteins (VLDL) were
observed for the SVD group in comparison to the
other anatomical categories and for the ACS in
comparison to other phenotypic severity categories.
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Association of variants at 11q23.3 chromosomal region
with anatomical categories of CAD
The test of association of variants at the 11q23.3 chromo-
somal region yielded 19 SNPs to be significantly associated
(p ≤ 0.05) with at least one of the four anatomical categories
of CAD which clearly implicates the potential role of these
variants in the manifestation of these categories. The minor
allele frequencies of the associated SNPs with respective
odds ratios are presented in Table 1. Seven, ten, nine, and
11 of these 19 SNPs are observed to be associated with in-
significant, SVD, DVD, and TVD categories, respectively.
However, while the risk-reducing effect of the intronic
BUD13 variant rs17440396:G>A and two APOA5-APOA4
intergenic variants rs633389:C>T and rs2849165:G>A is
consistent across the anatomical categories, rs6589566:A>G
of ZPR1 gene is consistently associated with increased risk.
Of the remaining three SNPs associated with insignificant
category, rs10488699:G>A and rs625524:G>A confer risk
and rs3741298:A>G is protective. Of the remaining six of
the nine SNPs associated with SVD, rs664059:C>T,
rs2075294:G>T, rs633867:C>T, rs5081:A>T, and rs6321
53:G>T are associated with increased risk while only
rs5072:C>T is associated with decreased risk. Among the
five remaining SNPs associated with DVD, while
rs1263163:G>A and rs7396835:C>T are associated with de-
creased risk rs1263171:G>A, rs2727793:G>A, and rs25420
63:G>A are with increased risk towards the condition.
Similarly, of the remaining seven SNPs associated with
TVD, while rs10488699:G>A, rs664059:C>T, rs20752
94:G>T, and rs1263171:G>A confer risk rs11600380:T>C,
rs1263163:G>A, and rs625524:G>A are protective in
nature. We applied a powerful yet less stringent
Benjamin-Hochberg (BH) correction for multiple test-
ing and found rs17440396:G>A to be highly signifi-
cantly associated across the anatomical categories,
while the two SNPs, rs6589566:A>G and rs28491
65:G>A, remained significantly associated with insig-
nificant, SVD, and DVD categories. The results of
genotypic association analysis of the above SNPs with
anatomical categories under the log-additive model
(Additional file 3) suggest a similar pattern of associ-
ation of the SNPs as in the case of allelic association,
except for rs3741298:A>G in case of insignificant
category and rs7396835:C>T in case of DVD and
both rs664059:C>T and rs2075294:G>T in case of
TVD. Among the variants that belong to BUD13,
ZPR1, and APOA5-APOA4 intergenic regions
(rs17440396:G>A, rs6589566:A>G, and rs2849165:
G>A), respectively, and found to be associated across
the anatomical categories of CAD, no particular trend
with increasing severity of the disease was evident in
the genotypic odds ratios. The observed pattern of
association may thus suggest the implicit pathophysi-
ology of the disease where the abnormal lipid
metabolism only triggers the process of atherosclerosis
and may not play a major role in further progression of
the disease [18]. Further, an increasing genotypic odds ra-
tio of the -75G>A (MspI) polymorphism in the promoter
region of APOA1 gene observed with increasing anato-
mical severity among the north Indians [11] and in an
Australian population [12] could not be observed in our
population. Concurrently, the significant association of
two variants, rs1225006 (Chromosome 3; CPNE4 gene)
and rs6745588 (Chromosome 2; STK39 gene), with triple
vessel disease discovered in a recent GWAS on Koreans
were not associated in a replication cohort [19]. Except for
this single GWAS study and a few validating studies on
9p21.3 variants and Msp1 APOA1 conventional poly-
morphism, genetic determinants of the clinical heterogen-
eity of CAD are hitherto poorly understood.
Association of variants at 11q23.3 chromosomal region
with phenotypic severity categories
The results of allelic association with each of the pheno-
typic severity categories are presented in Table 2. Overall,
15 SNPs were significantly associated (p ≤ 0.05) with at least
one of the three phenotypic severity categories. However,
only four of the 15 SNPs in case of angina, eight in case of
ACS and 11 in case of MI phenotypes were individually as-
sociated. Among these 15, only two SNPs, rs17440396:G>A
and rs633389:C>T, were commonly associated with
decreased risk towards all the three phenotypic severity
categories. The remaining two SNPs rs6589566:A>G and
rs1263167:A>G associated with angina are risk conferring
in nature. Of the six remaining SNPs associated with ACS,
while rs2187126:A>G and rs2849165:G>A were associated
with decreased risk, rs664059:C>T, rs6589566:A>G,
rs2075294:G>T, and rs633867:C>T were associated with in-
creased risk towards the condition. In case of MI, while the
seven of the nine remaining SNPs (rs10488699:G>A,
rs664059:C>T, rs2075294:G>T, rs1263171:G>A, rs284917
6:G>C, rs5081:A>T ,and rs632153:G>T) were found to be
risk conferring, rs1263163:G>A and rs2849165:G>A are
risk reducing in nature. The observed trend of increasing
number of risk conferring SNPs associated with increasing
phenotypic severity (angina to MI) imply that the variants
at 11q23.3 chromosomal region might regulate the pheno-
typic severity. However, when non MI-angina cases were
used as controls in the analysis, none of these additional
risk variants turned out to be significant except for the risk
reducing effect of rs1263163:G>A on MI, reflecting its
specificity towards MI. After correction for multiple testing,
while only rs17440396:G>A exhibited significant associ-
ation with all the three phenotypic categories, rs658956
6:A>G and rs2849165:G>A show significant association
with angina and ACS and ACS and MI categories,
respectively.
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Except for the three of the above 15 SNPs, rs12631
67:A>G, rs2075294:G>T, and rs632153:G>T that failed to
show significant association with angina, ACS, and MI cat-
egories, respectively, the results of genotypic association
with the phenotypic severity categories under the log-
additive model suggest similar pattern as that of the allelic
association (Additional file 4). Nevertheless, those three
SNPs which lost significance were the ones with marginal
significance (p =~0.05) in case of allelic association, and
these departures can be attributed to chance fluctuations
because of small sample sizes.
Pattern of association of genetic variants with anatomical
and phenotypic severity categories of the CAD patients
using subsets of controls
The control cohort of the present study constitutes two
kinds of subjects: (1) those presenting any one or more of
the conditions like dyslipidemia, diabetes, and hyperten-
sion and (2) those having none of these conditions. In
order to determine the confounding effects of these clin-
ical risk factors, particularly dyslipidemia, we repeated the
allelic association analysis by using only nondyslipidemic
cohort of controls (cohort 1; n = 270) and those devoid of
any of the three conditions—dyslipidemia, diabetes and
hypertension (cohort 2; n = 129) and present here only the
salient features of the findings of this exploratory analysis.
Overall, a consistent pattern of association of the SNPs
rs17440396:G>A, rs6589566:A>G, rs2849165:G>A, rs104
88699:G>A, rs1263163:G>A, and rs1263171:G>A is ob-
served with both anatomical and/or phenotypic severity
categories, which needs to be explored further for their
functional role. The respective p values for these SNPs
after BH correction for multiple testing in the three sets of
controls (total controls, cohort 1, and cohort 2) are
presented in Table 3. Certain inconsistencies observed
with reference to SNPs that showed significant association
at p ≤ 0.05 could be due to sampling errors possibly
emanated from reduced sample size for the subsets of
control. The salient features of the results are the
following:
1. The rs17440396:G>A is significantly associated
across the anatomical and phenotypic categories,
irrespective of control cohorts used in the analysis.
2. The rs6589566:A>G is significantly associated with
insignificant, SVD, and DVD categories in the
analysis using total controls and insignificant and
DVD anatomical categories in cohort 1 analysis.
Further, this variant is associated with angina and
ACS phenotypic severity categories irrespective of
control cohorts used in the analysis.
3. The rs2849165:G>A is significantly associated with
insignificant, SVD, and ACS categories irrespective
of the control cohort used. However, it is associated
with DVD in the analysis using total controls or
cohort 1 and MI using total controls.
4. The rs10488699:G>A and rs1263163:G>A variants
are found associated with MI irrespective of control
cohorts used in the analysis.
While rs633389:C>T is significantly associated with DVD
when total controls were used, rs5081:A>T, rs633867:C>T,
Table 2 Association of variants at 11q23.3 chromosomal region with stable/unstable angina, ACS, and MI categories
SNP Control (n = 462) Angina (n = 73) Acute coronary syndrome (n = 165) Myocardial infarction (n = 76)
MAF MAF p value OR (95% CI) MAF p value OR (95% CI) MAF p value OR (95% CI)
rs17440396:G>A 0.21 0.01 1.36 × 10−08 0.05 (0.01–0.21) 0.03 5.15 × 10−14 0.12 (0.06–0.23) 0.03 6.89 × 10−08 0.10 (0.04–0.28)
rs10488699:G>A 0.20 0.34 0.0001 2.08 (1.41–3.07)
rs2187126:A>G 0.13 0.09 0.025 0.61 (0.39–0.94)
rs664059:C>T 0.30 0.37 0.029 1.34 (1.03–1.75) 0.41 0.0080 1.61 (1.13–2.30)
rs6589566:A>G 0.25 0.46 5.63 × 10−07 2.56 (1.75–3.73) 0.43 3.36 × 10−09 2.23 (1.70–2.92)
rs2075294:G>T 0.05 0.08 0.049 1.63 (1.00–2.66) 0.10 0.026 1.97 (1.07–3.62)
rs633389:C>T 0.16 0.06 0.0027 0.36 (0.18–0.72) 0.09 0.0054 0.56 (0.37–0.85) 0.07 0.0053 0.41 (0.22–0.78)
rs633867:C>T 0.06 0.09 0.015 1.77 (1.11–2.82)
rs1263163:G>A 0.20 0.03 1.64 × 10−08 0.11 (0.04–0.29)
rs1263167:A>G 0.09 0.15 0.037 1.70 (1.03–2.82)
rs1263171:G>A 0.43 0.52 0.040 1.44 (1.02–2.03)
rs2849165:G>A 0.36 0.17 1.18 × 10−10 0.35 (0.26–0.49) 0.23 0.0013 0.51 (0.34–0.77)
rs2849176:G>C 0.49 0.59 0.032 1.46 (1.03–2.08)
rs5081:A>T 0.03 0.07 0.0203 2.28 (1.12–4.65)
rs632153:G>T 0.03 0.06 0.035 2.18 (1.04–4.59)
Blank cell—not significant
OR odds ratio obtained from logistic regression analysis
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and rs632153:G>T showed significant association with SVD
and rs1263171:G>A with TVD in case of control cohort 1.
Results of SNP-SNP interaction analysis
While the rs17440396:G>A of BUD13 gene showed risk
reducing effects, rs10488699:G>A variant that belongs to
the same gene is associated with increased risk particularly
for severe forms of anatomical and phenotypic conditions.
Similarly, rs3741298:A>G that belong to ZPR1 gene is
associated with risk-reducing effect specific to the insig-
nificant category despite the high risk conferring nature
towards CAD due to rs6589566:A>G variant. Therefore,
we performed pair wise logistic regression analysis to
understand the interaction effects of these SNPs on the
anatomical and phenotypic categories of CAD. From the
pairs of SNPs that showed significant interactions, the
following types of interactions can be inferred:
1. Interactions between intronic SNPs of BUD13
regulatory gene and intergenic SNPs of APOA5-
APOA4 genes.
2. Intronic SNPs of ZPR1 and BUD13 genes.
3. Intronic SNPs of ZPR1 gene and Intergenic SNPs of
APOA5-APOA4.
4. Interactions among the variants of APOA5-APOA4
intergenic region.
The pair wise SNP-SNP interactions associated with
anatomical categories of CAD are presented in Table 4.
The interaction odds ratio of SNPs suggests epistatic
effects of rs3741298:A>G over rs6589566:A>G resulting
in reducing risk for SVD. While rs2187126:A>G–
rs1263171:G>A (OR= 6.07, p value = 3.81 × 10−06) that is
characteristic of type 1 interaction is associated with in-
creased risk towards SVD, rs6589566:A>G–rs1263163:G>A
(OR = 5.39, p = 1.55 × 10−05) of type 3 interaction showed
increased risk towards insignificant category. Most of the
interactions of variants of BUD13 with variants of APOA4-
APOA5 intergenic region exhibit risk reducing effects to
SVD. Further, a type 4 SNP-SNP interaction, rs12631
63:G>A–rs2849165:G>A is observed to exhibit risk redu-
cing effects across the anatomical categories while the type
2 interaction, namely, rs6589566:A>G–rs3741298:A>G,
showed similar effect only towards SVD.
The interaction analysis with phenotypic severity
categories suggests significant SNP-SNP interactions
towards angina and ACS categories but not with MI
category. Pertaining to angina, only two SNP pairs, namely,
rs2187126:A>G–rs1263163:G>A (odds ratio = 0.01; p value
Table 3 P values for variants that were significantly associated after Benjamin Hochberg correction for multiple testing
SNP Control
choice
Anatomical category (p values) Phenotypic severity categories (p values)
Insignificant SVD DVD TVD ANGINA ACS MI
rs17440396:G>A Total Controls 4.92 × 10−08 1.49 × 10−08 2.02 × 10−05 0.0001 1.43 × 10−06 1.04 × 10−11 6.79 × 10−06
Cohort 1 2.36 × 10−06 2.13 × 10−06 0.0005 0.0027 2.54 × 10−05 4.78 × 10−09 0.0001
Cohort 2 1.77 × 10−06 2.47 × 10−06 0.0004 0.0021 2.18 × 10−05 1.55 × 10−08 0.0001
rs6589566:A>G Total Controls 0.0001 0.012 0.0008 2.61 × 10−05 1.26 × 10−07
Cohort 1 0.017 0.044 0.004 0.0005
Cohort 2 0.036 4.70 × 10−06
rs2849165:G>A Total Controls 0.001 0.001 0.0093 7.65 × 10−09 0.026
Cohort 1 0.011 0.010 0.044 4.30 × 10−07
Cohort 2 0.015 0.016 0.020
rs10488699:G>A Total Controls 0.004
Cohort 1 0.0007
Cohort 2 0.018
rs1263163:G>A Total Controls 7.83 × 10−06
Cohort 1 0.0033
Cohort 2 0.011
rs633389:C>T Total Controls 0.014
rs5081:A>T Cohort 1 0.047
rs633867:C>T Cohort 1 0.047
rs632153:G>T Cohort 1 0.047
rs1263171:G>A Cohort 1 0.046
Blank cell—not significant, total control samples (n = 462), cohort 1—nondyslipidemic control cohort (n = 270), cohort 2—control cohort devoid of dyslipidemia,
diabetes, and hypertension (n = 129)
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= 6.4 × 10−05) and rs1263163:G>A–rs2849165:G>A (odds
ratio = 0.03; p = 1.5 × 10−09) characteristic of type 1 and
type 2 interactions, respectively, showed significant
risk-reducing effects towards the condition. The inter-
actions associated with ACS (Table 5) are of type 1, and
type 4, and confer significant risk-reducing effects to-
wards the condition. Further, eight SNPs of BUD13
gene individually showed significant interaction with
rs6589566:A>G of ZPR1 gene with six of these interac-
tions being risk conferring towards the ACS (Table 5).
Besides this, the interaction of rs6589566:A>G with an
APOA5-APOA4 intergenic variant rs1263163:G>A is
also risk conferring towards ACS.
The observed trait specific associations might be due
to the pleiotropic nature of BUD13 and ZPR1 regulatory
genes and their interaction with variants at APOA5-
APOA4 intergenic region. Being the component of
retention and spliceosome (RES) complex, BUD13 pro-
tein acts as splicing factor for a number of genes and is
involved in controlling pre-mRNA retention in the
nucleus [20, 21]. ZPR1 is another prominent pleiotropic
regulatory gene whose deficiency causes defects in DNA
replication, transcription, and cell cycle regulation [22].
However, the putative pleiotropic effects of these genes
in atherosclerosis need to be validated through in vitro
functional experiments. Although the present study
Table 5 Significant SNP-SNP interaction odds ratios from pair wise logistic regression with acute coronary syndromea
Type of interaction SNP pair Odds ratio p value
BUD13–intergenic variants of
APOA5-APOA4 genes
rs10488699:G>A rs633389:C>T 0.17 1.48 × 10−05
rs10488699:G>A rs1263163:G>A 0.10 9.82 × 10−09
rs2187126:A>G rs633389:C>T 0.04 1.95 × 10−07
rs2187126:A>G rs1263163:G>A 0.06 5.17 × 10−08
Intronic variants of
BUD13–ZPR1–genes
rs11216126:A>C rs6589566:A>G 2.62 2.11 × 10−05
rs11216129:C>A 2.48 8.22 × 10−05
rs180326:A>G 0.36 5.61 × 10−05
rs2075295:T>C 2.76 2.46 × 10−06
rs17119975:T>C 2.66 1.71 × 10−05
rs1263149:A>G 0.34 1.78 × 10−06
rs623908:A>G 2.39 4.17 × 10−05
rs2041967:A>G 2.69 4.67 × 10−06
ZPR1–intergenic variants of
APOA5-APOA4 genes
rs6589566:A>G rs1263163:G>A 4.31 4.59 × 10−06
Within the intergenic variants of
APOA5-APOA4 genes
rs1263163:G>A rs1263171:G>A 0.35 2.87 × 10−05
rs1263163:G>A rs2849165:G>A 0.04 2.85 × 10−12
aNo SNP-SNP interaction was significant in case of angina and MI
Table 4 Significant SNP-SNP interaction odds ratios from pair wise logistic regression with anatomical categories
Type of interaction SNP pair Associated category Odds ratio p value
BUD13–intergenic variants of
APOA5-APOA4 genes
rs10488699:G>A–rs1263163:G>A Insignificant 0.13 4.43 × 10−06
rs2187126:A>G–rs1263163:G>A Insignificant 0.04 3.11 × 10−06
rs10488699:G>A–rs1263163:G>A SVD 0.06 2.26 × 10−07
rs2187126:A>G–rs633389:C>T SVD 0.06 8.28 × 10−07
rs2187126:A>G–rs1263163:G>A SVD 0.02 3.00 × 10−07
rs2187126:A>G–rs1263171:G>A SVD 6.07 3.81 × 10−06
Intronic variants of ZPR1–BUD13
genes
rs6589566:A>G–rs3741298:A>G SVD 0.29 1.36 × 10−05
ZPR1–intergenic variants of
APOA5-APOA4 genes
rs6589566:A>G–rs1263163:G>A Insignificant 5.39 1.55 × 10−05
Within the intergenic variants of
APOA5-APOA4 genes
rs1263163:G>A–rs2849165:G>A Insignificant 0.03 1.12 × 10−10
SVD 0.06 7.70 × 10−09
DVD 0.03 1.90 × 10−07
TVD 0.06 9.06 × 10−06
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included (i) missense and nonsense variants and (ii) vari-
ants in the noncoding regions such as promoters, 5′ or 3′
untranslated regions (UTR), upstream and downstream
elements, and intergenic regions, we observed the intronic
SNPs of BUD13 and ZPR1 genes and intergenic SNPs of
APOA5-APOA4 genes to be mostly associated with CAD
and/or its categories. In fact, most of the SNPs that belong
to this region and associated with abnormal lipid traits
through GWAS approach are localized to noncoding
domains, which has also been the characteristic pattern of
association of the genomic regions with other complex
genetic diseases. Further, the candidate gene association
studies for risk factors of CAD observed several conven-
tional polymorphisms such as 3238 C>G Sac1 (3′UTR
SNP of APOC3 gene), −1131 C>T (promoter SNP of
APOA5 gene), −75G>A, and +83C>T (promoter SNPs of
APOA1 gene) that belong to the noncoding domains of
this genomic region [3, 4, 23, 24]. The outcome of
ENCODE project also suggests that the noncoding variants
may be involved in regulation of gene expression depend-
ing on the cell type, developmental stage, and environmen-
tal factors [25, 26] and thus have multiple targets.
Prioritization of intergenic SNPs through computational
tools and subsequent validation through expression GWAS
presents a promising strategy for understanding the under-
lying mechanisms of CAD [27]. For example, Musunuru et
al. [28], identified a single noncoding DNA variant
rs12740374 at 1p13.3 chromosomal region to influence
LDLC and MI risk via liver specific transcriptional regula-
tion of the SORT1 gene by C/EBP transcription factors,
providing insights into mechanisms by which the nonco-
ding genetic variants can lead to clinical phenotypes.
Risk score analysis
In order to determine the combined risk effect of the
associated SNPs towards each of the anatomical and
Fig. 1 ROC analysis indicating discriminative power of the variants for anatomical categories of CAD. a Insignificant CAD. b Single vessel disease.
c Double vessel disease. d Triple vessel disease
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phenotypic categories, we computed the weighted mean
proportion of the risk alleles of the SNPs by taking 2 for
two risk alleles, 1 for one risk allele, and 0 for no risk alleles
with weights as relative log odds ratios of different SNPs.
The cumulative risk allele score for each individual is ob-
tained by multiplying with number of SNPs associated with
the clinical category. The risk scores for individuals
ranged from 1.5 to 12.5, 0.5 to 15.5, 0.5 to 18.5, and
5.5 to 17.5 in case of insignificant, SVD, DVD, and
TVD anatomical conditions of CAD, respectively.
Similarly, the ranges are 0 to 8.5, 0.5 to 14.5, and 3.5
to 18.5 in case of angina, ACS, and MI, respectively.
We grouped the risk scores with very low frequencies
into the adjacent category. The details of risk categor-
ies and the risk scores constituting each of those cat-
egories are furnished in (Additional file 5: Table S5)
and (Additional file 6: Table S6), according to each of
the anatomical and phenotypic severity conditions.
The results suggest a clear trend of increase in the
proportion of cases with increasing risk score. With
reference to baseline category with lowest risk scores, we
computed odds ratios for each of the remaining risk cat-
egories. An increasing trend of OR values with increasing
risk score is apparent with all the clinical conditions of
CAD (Additional files 7 and 8). Except for the risk category
1 of ACS, the odds ratios suggest significant associations
with clinical categories of CAD. To gauge discriminative
power of the risk scores, we constructed the ROC (receiver
operating curve) plot (Figs. 1 and 2) for the risk scores and
status of the clinical categories of CAD. The observed area
under curve (AUC) indicates that this study has substantial
and significant power to confer these genetic variants as
predictors for clinical conditions of CAD.
Conclusions
The intrinsic biological processes and methodological
aspects have always been confounding factors for stud-
ying complex diseases, which led to inconsistent results
Fig. 2 ROC analysis indicating discriminative power of the variants for phenotypic severity categories of CAD. a Angina. b Acute coronary syndrome.
c Myocardial infarction
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in genetic studies based on candidate gene and genome
wide approaches [29, 30]. Although several attempts
were made to minimize the confounding effects of these
factors, the genetic background of characteristic clinical
heterogeneity of CAD is not well addressed until
recently [7]. From the results of our study, it may be
hypothesized that a complex interaction between the
intronic domains of regulatory genes and intergenic
protein coding genes at 11q23.3 chromosomal region is
involved in regulating the lipid traits. The high discrim-
inative power of the variants further implicates their
significant role in developing various forms of CAD.
Given the relatively smaller sample sizes for the sub phe-
notypes, the statistical power for our study is somewhat
limited and hence this study can be considered only ex-
ploratory in nature. Nevertheless, because of the paucity
of such studies, we still believe that our results would
provide useful insights into the possible genetic mecha-
nisms behind the phenotypic heterogeneity of CAD,
which might help in aptly designing future studies based
on much larger samples.
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